News|Articles|July 30, 2026
To Aggregate or not to aggregation (It's not really a question)
Author(s)Korber
Breaking cases or building mixed pallets? Learn why aggregation is essential for maintaining serialized product relationships without adding costly scans, errors and operational delays.
Related Content
Trending on PharmExec
1
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
2
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
3
President Trump Set to Nominate Heidi Overton as FDA Commissioner
4
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
5